Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.80
-0.52 (-8.23%)
At close: Apr 2, 2026, 4:00 PM EDT
5.74
-0.06 (-1.07%)
After-hours: Apr 2, 2026, 6:18 PM EDT
Decoy Therapeutics Employees
Decoy Therapeutics had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,502,379
Market Cap
3.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | -10 | -83.33% | 2 | 0 |
| Dec 31, 2022 | 12 | -4 | -25.00% | 12 | 0 |
| Dec 31, 2021 | 16 | 7 | 77.78% | 16 | 0 |
| Dec 31, 2020 | 9 | 1 | 12.50% | 7 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IO Biotech | 78 |
| GeoVax Labs | 17 |
| Genprex | 13 |
| Azitra | 13 |
| Galmed Pharmaceuticals | 6 |
| Alzamend Neuro | 6 |
| Enveric Biosciences | 6 |
| Indaptus Therapeutics | 5 |
DCOY News
- 9 hours ago - Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 22 days ago - Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - PRNewsWire
- 4 weeks ago - Decoy Therapeutics Announces 1-for-12 Reverse Stock Split - PRNewsWire
- 7 weeks ago - Decoy Therapeutics Joins Webull Corporate Connect Service Platform - PRNewsWire
- 2 months ago - Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - PRNewsWire
- 2 months ago - Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement - PRNewsWire
- 2 months ago - Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - PRNewsWire
- 3 months ago - Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics - GlobeNewsWire